Nico Gagelmann/LinkedIn
Aug 22, 2026, 14:41
Nico Gagelmann: What is the Future for Patients with Myeloproliferative Neoplasms?
Nico Gagelmann, Research Fellow at Dana-Farber Cancer Institute, shared a post on LinkedIn:
“What is the future for patients with myeloproliferative neoplasms?
A snapshot from the episode of MYTHS & FACTS on Hematology and Cell Therapy with Claire Harrison.
Watch or listen to the full episode with lots more nuanced and deep insights on Youtube and on Spotify.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Aug 22, 2026, 17:05Mostafa Elshazly: Managing Anticoagulant-Related Bleeding in Clinical Practice
-
Aug 22, 2026, 17:01Cesarovic Nikola: FDA Data Reanalysis Raises Questions About Moderna’s mFLUSIVA Risk-Benefit Profile
-
Aug 22, 2026, 16:38Andreas Linkermann: Decoding the Chain Reaction of Ferroptotic Cell Death
-
Aug 22, 2026, 16:33Nicolas Hulscher: FDA Data Reanalysis Raises Alarms Over Moderna’s MFLUSIVA
-
Aug 22, 2026, 16:19Moti Haim: Transforming AF Care in the Elderly
-
Aug 22, 2026, 16:12Hussam Hammoud: A Slap Is Not “Just a Slap” When the Patient Has Hemophilia
-
Aug 22, 2026, 15:53Howard Smith: Publix’s GreenWise Organic Frozen Berries Have E. coli Contamination
-
Aug 22, 2026, 15:13Arthur Allen: Empowering Clinicians to Act
-
Aug 22, 2026, 15:11Bassem M. Mohammed: Factor VIII Structure Analysis Makes the Cover of the Journal of Thrombosis and Haemostasis